Company / EPS (Basic)
Emergent BioSolutions Inc. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.98
FY2025
5-year range
-$14.85 / $5.79
FY2021-FY2025
Trend
+127.2%
vs FY2024
Sector context
#33 of 208
Health Care
What the data says
Emergent BioSolutions Inc.'s eps (basic) of $0.98 is higher than 84% of companies in the Health Care sector (FY2025). EPS (Basic) has fluctuated over the past 10 years, ranging from $-14.85 in FY2023 to $5.79 in FY2022.
Based on SEC 10-K filings.
0.98 in FY2025 with a 5-year CAGR of -4.8%. Top quartile in the Health Care sector.
Improved from $-14.85 to $0.98 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -44.7%
- 5-Year CAGR
- -4.8%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 208This company $0.98 Sector average -$0.87
▼
+212.6% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 127.2% year-over-year.
- Ranks #33 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2022.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.98 | +127.2% |
| FY2024 | -$3.60 | +75.8% |
| FY2023 | -$14.85 | -356.5% |
| FY2022 | $5.79 | +41.2% |
| FY2021 | $4.10 | +228.0% |
| FY2020 | $1.25 | +17.9% |
| FY2019 | $1.06 | -17.8% |
| FY2018 | $1.29 | -20.9% |
| FY2017 | $1.63 | +66.3% |
| FY2016 | $0.98 | +14.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026